SCHEMBL29958047

SCHEMBL29958047

CS(=O)(=O)OCc1nc(Cl)cc(OCc2cn3cc(C4CC4)ccc3n2)n1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 19/20 0.37
▸ METTL3 Q86U44 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27033862 1.00 KLKB1 (0.37) KLKB1METTL3
SCHEMBL27033810 0.85 METTL3 (0.40) KLKB1METTL3
SCHEMBL29958202 0.85 METTL3 (0.40) KLKB1METTL3
SCHEMBL29958235 0.80 KLKB1 (0.41) KLKB1METTL3
SCHEMBL27033696 0.80 KLKB1 (0.41) KLKB1METTL3
SCHEMBL29957846 0.79 METTL3 (0.41) KLKB1METTL3
SCHEMBL27033446 0.79 METTL3 (0.41) KLKB1METTL3
SCHEMBL29957915 0.79 METTL3 (0.42) KLKB1METTL3
SCHEMBL29957358 0.79 METTL3 (0.38) KLKB1METTL3
SCHEMBL27033652 0.79 METTL3 (0.38) KLKB1METTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308228-A1 PLASMA KALLIKREIN INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2024-01-24 — — EP disclosed
WO-2022197756-A1 PLASMA KALLIKREIN INHIBITORS SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback